Dr Jolyon Martin is the only honouree from an animal health firm
PetMedix co-founder Dr Jolyon Martin has been included in the Forbes 30 Under 30 Europe List for Science and Healthcare 2021.
The 28-year-old head of business development has been instrumental in translating human health technology breakthroughs into companion animals.
While undertaking his PhD at the University of Cambridge, Dr Martin developed a transgenic mouse platform that can create fully canine antibodies - technology that now forms the basis of the PetMedix technology.
Dr Martin commented: “I am honoured to be included in the Forbes 30 Under 30 list, and excited to join the global network of fellow entrepreneurs. I’ve always had a passion for animals, having been surrounded by dogs growing up.
“We also have increasing evidence about the close links between the health and welfare of pets and their human owners. I am thrilled that my work at PetMedix, developing therapeutics to fill a yawning gap in the provision of precision medicine for pets, has been recognised among such outstanding fellow honourees.”
The Forbes list contains young entrepreneurs across 10 categories who have achieved excellence in their field. Dr Martin is the only honouree from an animal health firm to be included on this year’s list.
Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.
